about
Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-AnalysisThe erythropoietin and regenerative medicine: a lesson from fish.Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all.Management of patients after renal graft loss: an open question for nephrologists.Restoring the dysfunctional endothelium.Caffeine and the kidney: what evidence right now?Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.Pregnancy in uremic patients: an eventful journey.Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.Dialysis and the elderly: an underestimated problem.Arrhythmias and hemodialysis: role of potassium and new diagnostic tools.Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology.The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists.The Dark Side of Blocking RAS in Diabetic Patients with Incipient or Manifested Nephropathy.Nephro-oncology: a link in evolution.Direct inhibition of plasmatic renin activity with aliskiren: a promising but under-investigated therapeutic option for non-diabetic glomerulonephritis.Kidney disease and psoriasis: novel evidences beyond old concepts.Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy.Renal denervation for resistant hypertension.Effect of pentoxifylline on renal outcomes in chronic kidney disease patients: A systematic review and meta-analysis.Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R).Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients.Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.Serum β-crosslaps as predictor of long-term parathyroid hormone levels in hemodialysis patients.Tumour markers and kidney function: a systematic review.Circulating progenitor cells after cold pressor test in hypertensive and uremic patients.Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization.Dialysis-related genotoxicity: sister chromatid exchanges and DNA lesions in T and B lymphocytes of uremic patients. Genomic damage in patients on hemodiafiltration.Effects of haemodialysis on circulating endothelial progenitor cell count.Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement?Acute kidney injury in patients undergoing cardiac surgery.Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials.Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis.Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension.Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure.Cochrane corner: renal denervation for resistant hypertension-a broken promise?
P50
Q26799740-5F817E15-7399-42CA-9B49-F4F144BE380EQ33483623-62B7843F-9D19-460E-81BC-99D311BD9768Q33750340-A23D8A37-D90A-4EAB-A66D-A0E83D30DBCDQ36480289-DB8A0806-22D7-4871-A749-6F6797D47CDBQ36789678-1601ED61-AF06-4293-8623-591E25AF460EQ36857167-4C7E9EB8-5398-4DEF-9F57-06783FE764F9Q37075834-EA2769FE-28B8-4951-B49E-A7DA449058F0Q37087937-8917AD70-2BF9-47C5-9AD7-91BBFCC17A2BQ37138568-CA9763F2-D1DD-4B77-B435-A90C46F85467Q37251326-3CF3F821-706C-4898-8C41-1D8DEF8F0249Q37303677-4A76778A-5B87-42F6-BA3E-BD4F5DEBDD63Q37368059-8C4A5CFA-754A-460A-A0A6-6864CD2B7729Q37525013-9755BBD9-B238-4DB9-8F59-B2161F4A8C58Q37736542-5A561B37-A02A-43AA-89FA-F4B9BC8FDA7EQ38520954-44A2B022-064A-4521-82D3-96E5B48B11EAQ38526078-3317FF40-038F-469C-B2EA-80DF353484BDQ38554467-693CAE9C-59B6-4868-9378-E5DBEA3593B1Q38599694-10CDC256-24E1-47E6-8C6C-790D10A13AC6Q38651883-90B4BA38-088D-4ECB-910D-9E2F3912E5ADQ38739958-65E53544-5283-4230-B2CF-2B9C23749A6AQ38755127-7DBD76A6-850F-4811-877E-CBE9BC305BF3Q38781838-5DFDAC4C-C555-45DA-ACAB-1B8D7B42C656Q39883799-45DAD207-7376-4034-99A5-B566AE601C4CQ39884688-4F261547-8EE3-4DFF-B434-C99480D0C76BQ40074489-895F9FFE-71E6-42A0-B686-B568849B466FQ41549377-7A28D84A-96F1-4CFB-850F-5C67B5954329Q41858828-306676FA-9237-49E7-AEDD-6FE4C91EA1B0Q42439034-CB0E5C11-2260-4D81-B996-FE773736349AQ42456673-494CF254-E8F6-4737-8C90-55D6945008E1Q42504580-FACF791C-6281-4895-83F6-A984203016E2Q42510972-A33B17CC-A16D-4435-96E2-C480819B99F0Q42789861-9F3B2BBC-F9B3-4E2F-A44B-58DD23767440Q43253122-F22D6852-A318-45F7-9CB4-DC4624CA7965Q45347439-08183CEB-7A92-4066-B3A8-BE546AA53DECQ46074635-F8680E37-0154-4B9F-9A93-25C1E73A6E5AQ47337535-9DABE49C-DA49-4AA0-87D3-AFF44C91046BQ48326465-84B33F18-E25D-4FC4-8337-C9E78E141E0FQ50774930-D9ECF41F-A247-4C3D-8552-FE8902054640Q51838552-6C570FE0-7204-4182-A66D-398CE36D67DDQ52869602-CC122B42-56CB-47F0-A77E-1F0DB2FCE8F9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giuseppe Coppolino
@ast
Giuseppe Coppolino
@en
Giuseppe Coppolino
@es
Giuseppe Coppolino
@nl
Giuseppe Coppolino
@sl
type
label
Giuseppe Coppolino
@ast
Giuseppe Coppolino
@en
Giuseppe Coppolino
@es
Giuseppe Coppolino
@nl
Giuseppe Coppolino
@sl
prefLabel
Giuseppe Coppolino
@ast
Giuseppe Coppolino
@en
Giuseppe Coppolino
@es
Giuseppe Coppolino
@nl
Giuseppe Coppolino
@sl
P106
P1153
8586340900
P21
P31
P496
0000-0001-8000-0681